+

NO20056223L - Preparat til behandling av infeksjon hos kveg og svin - Google Patents

Preparat til behandling av infeksjon hos kveg og svin

Info

Publication number
NO20056223L
NO20056223L NO20056223A NO20056223A NO20056223L NO 20056223 L NO20056223 L NO 20056223L NO 20056223 A NO20056223 A NO 20056223A NO 20056223 A NO20056223 A NO 20056223A NO 20056223 L NO20056223 L NO 20056223L
Authority
NO
Norway
Prior art keywords
pigs
treatment
cattle
infection
preparation
Prior art date
Application number
NO20056223A
Other languages
English (en)
Norwegian (no)
Inventor
Robert D Simmons
Keith A Freehauf
Kanwal Jit Varma
Allan J Weingarten
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of NO20056223L publication Critical patent/NO20056223L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Virology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20056223A 2003-05-29 2005-12-29 Preparat til behandling av infeksjon hos kveg og svin NO20056223L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47429403P 2003-05-29 2003-05-29
PCT/US2004/016841 WO2004110494A1 (fr) 2003-05-29 2004-05-28 Compositions pour le traitement des infections des bovins et des cochons

Publications (1)

Publication Number Publication Date
NO20056223L true NO20056223L (no) 2005-12-29

Family

ID=33551488

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20056223A NO20056223L (no) 2003-05-29 2005-12-29 Preparat til behandling av infeksjon hos kveg og svin

Country Status (24)

Country Link
US (2) US8034845B2 (fr)
EP (1) EP1626739B1 (fr)
JP (2) JP4728244B2 (fr)
KR (1) KR101132079B1 (fr)
CN (2) CN1795013A (fr)
AR (2) AR044437A1 (fr)
AU (2) AU2004247053B2 (fr)
BR (1) BRPI0410795B1 (fr)
CA (1) CA2526202C (fr)
CL (1) CL2004001293A1 (fr)
EC (1) ECSP056189A (fr)
ES (1) ES2492537T3 (fr)
IL (1) IL172224A0 (fr)
MX (1) MXPA05012827A (fr)
MY (1) MY146351A (fr)
NO (1) NO20056223L (fr)
NZ (1) NZ543594A (fr)
PE (1) PE20050386A1 (fr)
PL (2) PL380481A1 (fr)
RU (1) RU2359659C2 (fr)
TW (1) TW200505425A (fr)
UA (1) UA81676C2 (fr)
WO (1) WO2004110494A1 (fr)
ZA (1) ZA200509544B (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11090444B2 (en) 2018-06-15 2021-08-17 James T. Doubet Syringe adapter for medication
US11337894B2 (en) 2018-06-15 2022-05-24 James T. Doubet Syringe adapter for animal medication
US10709850B2 (en) 2018-06-15 2020-07-14 James T. Doubet Syringe adapter for medication
US11097058B2 (en) 2018-06-15 2021-08-24 James T. Doubet Syringe adapter for medication
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US6790867B2 (en) * 2002-05-20 2004-09-14 Schering-Plough Animal Health Corporation Compositions and method for treating infection in cattle and swine
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
UA82359C2 (uk) * 2003-04-03 2008-04-10 Schering Plough Ltd Композиція (варіанти) і спосіб лікування мікробних і паразитних інфекцій у великої рогатої худоби і інших тварин
MY146351A (en) 2003-05-29 2012-08-15 Schering Plough Ltd Compositions for treating infection in cattle and swine
EP1568369A1 (fr) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Utilisation du meloxicam pour le traitement de maladies respiratoires des porcs
DE602005010479D1 (de) * 2004-12-21 2008-11-27 Intervet Int Bv Injizierbare veterinärmedizinische zusammensetzung enthaltend florfenicol
GB0501220D0 (en) * 2005-01-21 2005-03-02 Norbrook Lab Ltd Anthelmintic composition
CA2667211A1 (fr) * 2006-11-01 2008-05-08 Pronova Biopharma Norge As Lipides omega-3 a substitution alpha en tant qu'activateurs ou modulateurs du recepteur active par proliferateurs de peroxisome (ppar)
US20100240616A1 (en) * 2006-11-01 2010-09-23 Anne Kristin Holmeide Novel lipid compounds
CA2672795A1 (fr) * 2006-12-13 2008-06-26 Schering-Plough Ltd. Promedicaments solubles dans l'eau de chloramphenicol, thiamphenicol et analogues de ceux-ci
MX2009006714A (es) * 2006-12-19 2009-08-31 Schering Plough Ltd Formulaciones efervescentes de florfenicol para adicion en sistemas de agua potable.
PE20091171A1 (es) * 2007-12-14 2009-08-03 Schering Plough Ltd Proceso para recuperar florfenicol y analogos de florfenicol
FR2925334A1 (fr) * 2007-12-21 2009-06-26 Ceva Sante Animale Sa Nouvelles compositions antibacteriennes
EP2321269B1 (fr) * 2008-07-30 2018-09-19 Intervet International B.V. Procede de preparation de composes aminodiol d'oxazoline proteges utiles comme produits intermediaires dans la production de florfenicol
CA2777366C (fr) 2009-10-12 2023-11-14 Boehringer Ingelheim Vetmedica Gmbh Recipients pour compositions comprenant du meloxicam
KR101140167B1 (ko) * 2009-11-04 2012-04-24 최기동 동물용 의약 조성물 및 이를 포함하는 동물용 의약품
BRPI1002021A2 (pt) 2010-01-21 2012-05-22 Nanocore Biotecnologia S A composições farmacêuticas para tratamento de infecções bacterianas
BRPI1002023A2 (pt) 2010-03-01 2011-10-25 Nanocore Biotecnologia S A forma farmacêutica sólida de dissolução rápida para tratamento de infecções bacterianas
CA2791805A1 (fr) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Utilisation de meloxicam pour le traitement a long terme de troubles musculo-squelettiques chez les chats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
PT2654785T (pt) * 2010-12-22 2019-06-25 Bayer Ip Gmbh Resposta imunitária melhorada em espécies bovinas
EP2925353B1 (fr) * 2012-11-29 2019-03-13 Cornell University Vaccin pour une maladie intra-utérine
EA028412B9 (ru) * 2014-08-08 2018-03-30 Александр Петрович Мерабишвили Фармацевтический препарат ветеринарного назначения
EA028381B1 (ru) * 2014-08-08 2017-11-30 Александр Петрович Мерабишвили Фармацевтический препарат ветеринарного назначения
RU2563826C1 (ru) * 2014-08-21 2015-09-20 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Инъекционная антибактериальная фармацевтическая композиция
JP2018518511A (ja) * 2015-06-26 2018-07-12 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ａｎｉｍａｌ Ｈｅａｌｔｈ Ｇｍｂｈ 細胞質ｄｎａ監視分子の調節方法
US10463656B2 (en) * 2017-01-05 2019-11-05 Iowa State University Research Foundation, Inc. Methods and compositions for prevention of feedlot bovine respiratory disease
US20190388625A1 (en) 2018-06-15 2019-12-26 James T. Doubet Syringe adapter for medication
USD890925S1 (en) 2018-06-15 2020-07-21 James T. Doubet Syringe adapter for medication
US12227485B2 (en) * 2018-06-25 2025-02-18 Intervet Inc. Compounds useful for the treatment of infection with Mannheimia haemolytica or Histophilus somni

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2671748A (en) * 1950-05-18 1954-03-09 Parke Davis & Co Composition of matter
ES8104203A1 (es) * 1979-02-05 1981-04-16 Schering Corp Un procedimiento para la preparacion de un compuesto d-(treo-1-aril-2-acilamido-3-fluor-1-propanol
US4235892A (en) * 1979-02-05 1980-11-25 Schering Corporation, Patent Dept. 1-Aryl-2-acylamido-3-fluoro-1-propanols, methods for their use as antibacterial agents and compositions useful therefor
US5105009A (en) * 1983-06-02 1992-04-14 Zambon S.P.A. Intermediates for the preparation of 1-(phenyl)-1-hydroxy-2-amino-3-fluoropropane derivatives
NZ234802A (en) * 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
US5663361A (en) * 1996-08-19 1997-09-02 Schering Corporation Process for preparing intermediates to florfenicol
AU5609798A (en) * 1996-12-20 1998-07-17 Alza Corporation Injectable depot gel composition and method of preparing the composition
AU731799B2 (en) 1997-05-06 2001-04-05 Norbrook Laboratories Limited Improvements in or relating to long-acting antimicrobials
CA2211949A1 (fr) * 1997-07-21 1999-01-29 David Farley Johnson Compositions non aqueuses a administrer par voie parenterale
JP2003512290A (ja) * 1997-09-10 2003-04-02 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての８ａ−アザライド
CN1205921C (zh) * 1997-12-03 2005-06-15 麦克公司 含有氢化蓖麻油的长效注射制剂
ES2359973T3 (es) * 1998-03-19 2011-05-30 MERCK SHARP &amp; DOHME CORP. Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas.
US6136838A (en) * 1998-03-19 2000-10-24 Merck & Co., Inc. Sulfurpentafluorophenylpyrazoles for controlling ectoparasitic infestations
US6174540B1 (en) * 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
JP2001226257A (ja) * 2000-02-17 2001-08-21 Material Eng Tech Lab Inc 溶液製剤
US6787568B1 (en) 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
AU1987802A (en) * 2000-11-29 2002-06-11 Lyotropic Therapeutics Llc Solvent systems for pharmaceutical agents
CN1649829A (zh) * 2002-03-08 2005-08-03 先灵-普劳有限公司 新型氟苯尼考类抗生素
US6790867B2 (en) * 2002-05-20 2004-09-14 Schering-Plough Animal Health Corporation Compositions and method for treating infection in cattle and swine
CN1507858A (zh) 2002-12-19 2004-06-30 王玉万 含氟化氯霉素的兽用液体制剂
UA82359C2 (uk) 2003-04-03 2008-04-10 Schering Plough Ltd Композиція (варіанти) і спосіб лікування мікробних і паразитних інфекцій у великої рогатої худоби і інших тварин
MY146351A (en) 2003-05-29 2012-08-15 Schering Plough Ltd Compositions for treating infection in cattle and swine
US7781421B2 (en) * 2003-05-29 2010-08-24 Washington University Neuroactive 13, 24-cyclo-18, 21-dinorcholanes and structurally related pentacyclic steriods
NZ547592A (en) * 2003-12-23 2009-07-31 Schering Plough Ltd Florfenicol prodrug having improved water solubility
US7361689B2 (en) * 2003-12-31 2008-04-22 Schering-Plough Animal Health Corporation Antibacterial 1-(4-mono- and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoroproponals and preparation thereof
DE602005010479D1 (de) * 2004-12-21 2008-11-27 Intervet Int Bv Injizierbare veterinärmedizinische zusammensetzung enthaltend florfenicol
KR20080049040A (ko) * 2005-09-07 2008-06-03 쉐링-프라우 리미티드 플로르페니콜에 대한 중간체로서 유용한 옥사졸리딘 보호된아미노디올 화합물의 개선된 제조방법
US8119667B2 (en) * 2005-12-29 2012-02-21 Schering-Plough Animal Health Corporation Carbonates of fenicol antibiotics
US20080153906A1 (en) * 2006-12-13 2008-06-26 Celly Chander S Water-Soluble Phenicol Prodrugs in a Lipophilic Vehicle System
CA2672795A1 (fr) * 2006-12-13 2008-06-26 Schering-Plough Ltd. Promedicaments solubles dans l'eau de chloramphenicol, thiamphenicol et analogues de ceux-ci
CA2672586A1 (fr) * 2006-12-13 2008-06-26 Schering-Plough Ltd. Promedicaments de florfenicol solubles dans l'eau et analogues
MX2009006714A (es) * 2006-12-19 2009-08-31 Schering Plough Ltd Formulaciones efervescentes de florfenicol para adicion en sistemas de agua potable.
US20090062397A1 (en) * 2007-04-27 2009-03-05 Schering-Plough Animal Health Corporation Compounds and methods for enhancing solubility of florfenicol and structurally-related antibiotics using cyclodextrins
CA2688432A1 (fr) * 2007-05-30 2008-12-11 Schering-Plough Ltd. Procede de preparation de composes aminodiol proteges par oxazoline utiles comme intermediaires du florfenicol
BRPI0814581A2 (pt) * 2007-07-25 2017-05-09 Intervet Int Bv processo para a preparação de um composto, e, composto.
EP2217207B1 (fr) * 2007-11-09 2019-01-09 Intervet International B.V. Formulation solide à libération rapide, sa préparation et son utilisation
PE20091171A1 (es) * 2007-12-14 2009-08-03 Schering Plough Ltd Proceso para recuperar florfenicol y analogos de florfenicol

Also Published As

Publication number Publication date
AU2004247053B2 (en) 2010-11-11
JP2006528705A (ja) 2006-12-21
AU2010235885A1 (en) 2010-11-11
IL172224A0 (en) 2009-02-11
RU2359659C2 (ru) 2009-06-27
KR101132079B1 (ko) 2012-04-20
RU2005141127A (ru) 2006-06-10
BRPI0410795B1 (pt) 2017-12-19
AR044437A1 (es) 2005-09-14
BRPI0410795A (pt) 2006-06-20
TW200505425A (en) 2005-02-16
CN102342925A (zh) 2012-02-08
ZA200509544B (en) 2007-01-31
AR101380A2 (es) 2016-12-14
PL1626739T3 (pl) 2014-10-31
ES2492537T3 (es) 2014-09-09
PL380481A1 (pl) 2007-02-05
CN1795013A (zh) 2006-06-28
MXPA05012827A (es) 2006-02-13
US8034845B2 (en) 2011-10-11
NZ543594A (en) 2010-03-26
JP2007269801A (ja) 2007-10-18
MY146351A (en) 2012-08-15
KR20060016093A (ko) 2006-02-21
UA81676C2 (ru) 2008-01-25
EP1626739B1 (fr) 2014-05-21
EP1626739A1 (fr) 2006-02-22
PE20050386A1 (es) 2005-06-23
ECSP056189A (es) 2006-08-30
US20040242546A1 (en) 2004-12-02
AU2004247053A1 (en) 2004-12-23
US9084719B2 (en) 2015-07-21
CL2004001293A1 (es) 2005-05-06
CA2526202A1 (fr) 2004-12-23
CA2526202C (fr) 2012-07-03
WO2004110494A1 (fr) 2004-12-23
US20120077764A1 (en) 2012-03-29
JP4728244B2 (ja) 2011-07-20

Similar Documents

Publication Publication Date Title
NO20056223L (no) Preparat til behandling av infeksjon hos kveg og svin
ECSP045442A (es) &#34;composiciones y metodo para el tratamiento de infección en ganado vacuno y porcino&#34;
CY1118936T1 (el) Φαρμακευτικες συνθεσεις και μεθοδοι για την αγωγη ή την προληψη νοσου σχετιζομενης με οξαλικο
BRPI0412526A (pt) composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica
NO20055144L (no) Preparat for behandling av mikrobielle og parasittiske infeksjoner hos storfe og andre dyr.
NO20043612L (no) Nye fluorenkarboksylsyre-estere, fremgangsmate for fremstilling derav og anvendelse derav som legemidler
NO20083780L (no) Topisk sammensetning omfattende en antibakteriell substans
CY1112376T1 (el) Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2
BRPI0510113A (pt) sìntese de tetraciclinas e análogos da mesma
CY1109119T1 (el) Φαρμακοτεχνικες μορφες παρατεταμενης απελευθερωσης που περιλαμβανουν λαμοτριγινη
NO20085338L (no) Substituerte 1,3-difenylpropanderivater, sammensetninger og anvendelser derav
CY1107480T1 (el) Χρηση aivlosin για την θepαπευτικη αγωγη και προληψη λοιμωξεων lawsonia σε χοιρους
WO2005018605A3 (fr) Nouvelle formulation
NO20044530L (no) Fremgangsmate for behandling av kognitive forstyrrelser
PA8459201A1 (es) Composicion farmaceutica antimastitica a base de extractos de origen natural y procedimiento para fabricarla
DK1251874T3 (da) Stabile farmaceutiske kompositioner og fremgangsmåde til fremstilling af disse, der omfatter et antibiotikum og et slimdrivende middel
NO20051159L (no) Preparater og fremgangsmater for behandling av sykdommer som viser feilsammensetting av aggregering av protein
NO20075272L (no) Humane GLP-1 &#34;mimetibodies&#34;, sammensetninger, fremgangsmater og anvendelser
AR039035A1 (es) Proteinas con dominios tipo ig bacterianos (big) presentes en especies de leptospira
BRPI0414223A (pt) uso de extratos de gentiana lutea como um agente antimicrobiano
EA200401523A1 (ru) Способы применения и композиции для диагностики и лечения инфекционного заболевания
DE60222528D1 (de) Impfstoff gegen Pferdearteritisvirus
ES1047419Y (es) Camilla perfeccionada para el tratamiento quiropractico.
NO20065853L (no) Hydrogelinterferonformuleringer
BR8202669U (pt) Dispositivo para limpeza das orelhas de cachorros

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载